//]]>

Breast Cancer Metastasis and Drug Resistance (Record no. 17606)

000 -LEADER
fixed length control field 04004nam a22004095i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150238.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 121116s2013 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781461456476
978-1-4614-5647-6
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC261-271
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 614.5999
Edition number 23
264 #1 -
-- New York, NY :
-- Springer New York :
-- Imprint: Springer,
-- 2013.
912 ## -
-- ZDB-2-SBL
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ahmad, Aamir.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Breast Cancer Metastasis and Drug Resistance
Medium [electronic resource] :
Remainder of title Progress and Prospects /
Statement of responsibility, etc edited by Aamir Ahmad.
300 ## - PHYSICAL DESCRIPTION
Extent XI, 413 p. 59 illus., 45 illus. in color.
Other physical details online resource.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Preface -- Breast Cancer Statistics -- Epidemiology of Breast Cancer in Women -- The Complexities of Racial Disparity in Breast Cancer -- Major signaling pathways involved in Breast Cancer -- Breast Cancer Heterogeneity in Primary and Metastatic Disease -- Understanding Triple-negative Breast Cancer -- The biology of the deadly love connection between obesity, diabetes and breast cancer -- Progression of Early Breast Cancer to an Invasive Phenotype -- Pre-clinical modeling of breast cancer – which model to choose? -- Modeling breast cancer progression in 4-D -- Bone Metastasis of Breast Cancer -- Cellular and Molecular Mechanisms Involved in Breaching of The Blood-Brian Barrier By Circulating Breast Cancer Cells -- Resistance to Anthracyclines and Taxanes in Breast cancer -- Understanding of Tamoxifen Resistance of Breast Cancer based on Integrative Bioinformatics Approaches -- Current understanding of drug resistance mechanisms and therapeutic targets in HER2 overexpressing breast cancers -- Platinum and ruthenium complexes for the therapy of breast cancer diseases.-Development of Notch Pathway Inhibitors for Cancer Therapy -- Systems Biology Approaches in Breast Cancer Studies -- Epigenetic Factors in Breast Cancer Progression -- Breast Cancer Stem Cells and miRNAs -- Breast Cancer Stem Cells: responsible for therapeutic resistance and relapse? -- MicroRNAs in Breast Cancer Research: Progress and Promise -- Index.
520 ## - SUMMARY, ETC.
Summary, etc This comprehensive book on breast cancer brings together some of the leading experts in an attempt to better understand breast cancer disease, the factors that make it lethal and current research progress, integrating both basic research with clinical implications. This volume covers the following core issues: i) heterogeneity in breast cancer – statistics, epidemiology, breast cancer subtypes, racial disparity and the associated challenges, ii) available and upcoming model systems in breast cancer research, iii) breast cancer metastasis to bones and brain, iv) drug resistance mechanisms in breast cancer against targeted therapies and v) recent developments in breast cancer research – state of current research directions / technologies / approaches. With its comprehensive coverage of topics related to breast cancer, this volume is expected to have a very wide appeal. It serves as an excellent source of reference for students/beginning researchers just setting foot in the field and interested in getting to know all the aspects of this disease. The book should also appeal to advanced and senior researchers by bringing everyone up-to-date with the most current knowledge on various breast cancer topics of utmost relevance
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Drug interactions.
Topical term or geographic name as entry element Biomedicine.
Topical term or geographic name as entry element Cancer Research.
Topical term or geographic name as entry element Drug Resistance.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9781461456469
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-1-4614-5647-6
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-05AUM Main Library2014-04-05 2014-04-05 E-Book   AUM Main Library614.5999

Languages: 
English |
العربية